Pbs2 Inhibitors
Pbs2 inhibitors belong to a distinct class of chemical compounds that exhibit a pronounced ability to modulate a specific cellular signaling pathway. These inhibitors are recognized for their capacity to interact with and hinder the activity of Pbs2, a protein that holds a pivotal role in transmitting signals within the cell. By targeting Pbs2, these inhibitors play a crucial role in the intricate regulatory network that governs cellular responses to various external stimuli. Through their binding interactions with Pbs2, these compounds can interfere with downstream signaling cascades, altering the transmission of critical intracellular messages.
The modulation of Pbs2 activity by these inhibitors could lead to the alteration of cellular processes that rely on the precise regulation of this signaling pathway. Extensive research has been conducted to understand the molecular mechanisms underlying the interaction between Pbs2 and its inhibitors, shedding light on the applications of these compounds in influencing cellular responses and contributing to a broader comprehension of cellular communication.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Doramapimod | 285983-48-4 | sc-300502 sc-300502A sc-300502B | 25 mg 50 mg 100 mg | $149.00 $281.00 $459.00 | 2 | |
BIRB 796 is a p38 MAP kinase inhibitor that indirectly affects Pbs2 by inhibiting the p38 signaling pathway. By binding to the ATP-binding pocket of p38, it prevents activation of downstream Pbs2 targets, disrupting cellular responses to stress and inflammation. | ||||||
VX 745 | 209410-46-8 | sc-361401 sc-361401A | 10 mg 50 mg | $183.00 $842.00 | 4 | |
VX-745 is a specific inhibitor of p38α MAP kinase, a kinase that modulates Pbs2 signaling. It interferes with the ATP-binding site of p38α, impairing its activation and downstream signaling cascades, leading to reduced Pbs2-mediated stress response pathways. | ||||||
Losmapimod | 585543-15-3 | sc-489299 sc-489299A | 10 mg 50 mg | $228.00 $825.00 | ||
Losmapimod inhibits p38 MAP kinase, thereby impacting Pbs2 pathways. It reduces the activity of p38, which is a key regulator of Pbs2-dependent stress responses and inflammation, leading to downregulated downstream signaling events. | ||||||
RWJ 67657 | 215303-72-3 | sc-204251 sc-204251A | 10 mg 50 mg | $185.00 $772.00 | 2 | |
RWJ 67657 targets p38 MAP kinase, a critical player in Pbs2 pathways. By binding to the ATP pocket of p38, it hinders the phosphorylation of Pbs2 substrates, resulting in impaired cellular stress and inflammatory responses. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $31.00 $128.00 $454.00 | 45 | |
SB202190 is a p38 MAP kinase inhibitor that indirectly influences Pbs2 signaling. It disrupts p38-mediated phosphorylation of Pbs2 substrates, impacting stress-related cellular processes and inflammation. | ||||||
PH-797804 | 586379-66-0 | sc-364579 sc-364579A sc-364579B | 5 mg 50 mg 500 mg | $92.00 $520.00 $2601.00 | ||
PH797804 is a p38 MAP kinase inhibitor that affects Pbs2 pathways. It impedes the activation of p38, leading to decreased phosphorylation of Pbs2 substrates and consequent attenuation of cellular stress and immune responses. | ||||||
SCIO 469 hydrochloride | 309913-83-5 | sc-361353 sc-361353A | 10 mg 50 mg | $205.00 $865.00 | 2 | |
SCIO-469 inhibits p38 MAP kinase, indirectly influencing Pbs2 pathways. By disrupting p38 signaling, it interferes with the downstream events regulated by Pbs2 in response to cellular stress and inflammation. | ||||||